Icade stock reacts to Goldman Sachs sell rating and sector pressures
Published on 09/08/2026 at 19:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Icade stock (ISIN FR0000035081) is drawing investor attention on September 8, 2026, as a new sell recommendation from a major investment bank and ongoing pressures in European real estate shape sentiment around the Paris-listed group.
Goldman Sachs rating and valuation signals
According to Goldman Sachs data reported via TipRanks on September 8, 2026, analyst Jonathan Kownator has reiterated a sell rating on Icade SA and set a price target of 16.70 EUR per share, while the broader analyst consensus remains at a hold with an average target of 21.88 EUR.The Globe and Mail / TipRanks
The same TipRanks-based overview notes that Icade SA’s market capitalization in London trading under the 0K4O symbol stands at about 1.36 billion EUR, paired with a negative price-earnings ratio of -7.27 as of the September 8, 2026 snapshot, underlining that earnings remain under pressure.The Globe and Mail / TipRanks For investors, the gap between the 16.70 EUR sell-side target and the 21.88 EUR average target is a key quantified measure of disagreement on the stock’s upside.
Voting-rights update and capital structure
On September 8, 2026, Icade released its monthly information concerning the total number of voting rights and shares for the status as of August 31, 2026, reaffirming its listing on Euronext Paris and the use of the ICAD ticker.Zonebourse / Icade release While the detailed breakdown of shares and theoretical voting rights is provided in the attached document to the release, the communication itself confirms that the company continues to manage its capital structure transparently and regularly, which matters for real estate investors focused on dilution and governance.
The same release explicitly confirms the ISIN FR0000035081 for Icade and states that the issuer remains traded on the Euronext market, underlining its status as a French listed real estate investment company subject to SIIC tax rules.Zonebourse / Icade release In the current environment of elevated financing costs, clarity about the share count and voting rights helps investors assess potential corporate actions, including dividends, scrip options or asset disposals.
Real estate environment and risk factors
The refreshed sell rating from Goldman Sachs must be viewed against a backdrop of higher interest rates and softer valuations in European listed property, where discount-to-net-asset-value debates are intense.The Globe and Mail / TipRanks With a price target of 16.70 EUR compared with the average sell-side target of 21.88 EUR, the bank is effectively signaling downside of about 23.6 percent versus consensus, a quantified expression of its more cautious stance.
For shareholders, key risks that typically inform such a negative rating in diversified office and healthcare real estate include refinancing at higher coupons, potential asset write-downs as capitalization rates rise, and slower disposals in a less liquid transaction market. In addition, a negative price-earnings ratio, as captured in the TipRanks-based snapshot with a P/E of -7.27, usually implies recent consolidated net losses, which can restrict dividend flexibility and leverage headroom.The Globe and Mail / TipRanks
Representative asset base and business profile
Icade operates as a major French real estate player with a portfolio that traditionally includes office properties, healthcare real estate and development activities, positioning it as a diversified landlord and developer on Euronext Paris.Boursier.com Representative assets for investors following the stock include office campuses in the Paris region and healthcare facilities leased on long contracts, which together underpin rental income and net asset value.
Stock price and trading venue context
Market snapshots in the recent period confirm that Icade stock is listed and traded on Euronext Paris under the ICAD ticker, with the company classified in the listed real estate sector and included in broader French equity indices such as the SBF 120.Zonebourse / Icade releaseEuronext SBF 120 overview While detailed intraday quotes, 52-week trading ranges and day-by-day volumes fall outside the most recent evidence set, the London-traded 0K4O line with a market capitalization of around 1.36 billion EUR as of September 8, 2026 offers a concrete valuation anchor that investors can compare against reported net asset values.The Globe and Mail / TipRanks
Icade stock key data
- Company: Icade SA
- ISIN: FR0000035081
- Ticker: ICAD
- Trading venue: Euronext Paris
- Market capitalization: 1,360,000,000 EUR (as of September 8, 2026)
- Sector / Industry: Listed real estate / Real estate investment and development
- Index membership: SBF 120
